An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent ...

A new study in eGastroenterology links gut dysbiosis with severe steatosis in metabolic dysfunction–associated steatotic ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting data on Vanoglipel (DA-1241), a ...

A new study in eGastroenterology links gut dysbiosis with severe steatosis in metabolic dysfunction–associated steatotic ...

In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.

Modern lifestyles are fueling a surge in fatty liver disease, a condition where excess fat accumulates in the liver. Early ...

What is Fatty Liver? Fatty liver, medically known as hepatic steatosis, occurs when there is an abnormal accumulation of fat ...

Once almost exclusively seen in older adults, fatty liver disease, which can be fatal if untreated, is now one of the world’s ...

An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent metabolic fatty liver disease from progressing towards more serious conditions, ...

Fatty liver is a condition in which excess fat accumulates in the liver cells. It is also called hepatic steatosis. People often associate it solely with excessive alcohol consumption, but few people ...

Study adds to existing literature that shows damaging impact of obesity-related conditions on large portions of US population ...